Objectives: To evaluate the associations between serum complement factor 3 (C3) and several anthropometrical, biochemical and lifestyle features in healthy young adults, emphasizing on the putative effect of selenium intake on C3 concentrations. Methods: This study enrolled 100 healthy young adults aged 18-34 years. Anthropometric and blood pressure measurements and lifestyle features were analyzed. Fasting blood samples were collected for the measurement of glucose, total cholesterol, HDL-cholesterol, LDL-cholesterol, triacylglycerols and C3 concentrations. Nail samples were collected for the analysis of selenium concentrations. Results: Values of BMI (P ¼ 0.034), sum of skinfold thicknesses (STs) (P ¼ 0.021), body fat mass (BFM) (P ¼ 0.023), percentage of overweight subjects (P ¼ 0.007), serum triacylglycerols (P ¼ 0.012) and nail selenium (P ¼ 0.001) were significantly different between subjects above and below the median of serum C3 concentrations. The following correlations with serum C3 were identified tricipital ST (P ¼ 0.033), sum of STs (P ¼ 0.012), BMI (P ¼ 0.008), BFM (P ¼ 0.018), waist-to-height ratio (P ¼ 0.016), serum glucose (P ¼ 0.045), serum triacylglycerols (P ¼ 0.001) and nail selenium (P ¼ 0.006). Circulating C3 showed a positive association with several adiposity markers such as BMI (P ¼ 0.001), waist circumference (P ¼ 0.006), waist-to-height ratio (P ¼ 0.002), BFM (P ¼ 0.025), as well as serum glucose (P ¼ 0.027) and triacylglycerols (Po0.001), whereas nail selenium was a statistically significant negative predictor of C3 concentrations (P ¼ 0.018). Conclusions: C3 seems to be related with selenium status and several anthropometrical and biochemical measurements linked to metabolic syndrome in apparently healthy young adults. These findings suggest a possible role for selenium intake in the modulation of C3, whose assessment may be an early marker of metabolic syndrome manifestations.
Introduction
The inflammatory response triggered in the white adipose tissue has been associated with a cycle that leads to insulin resistance, atherosclerosis and typical alterations of the metabolic syndrome (Dandona et al., 2004 (Dandona et al., , 2005 Moreno-Aliaga et al., 2005) . In addition, oxidative stress has been suggested as a potential inducer of inflammation and susceptibility to develop obesity and related diseases (Vincent and Taylor, 2006) .
The complement system is an important factor in innate immunity mechanisms (Sahu and Lambris, 2001) . In this context, complement factor 3 (C3) plays a main role in the activation of the three complement activation pathways: classical, alternative and mannose-binding lectin (Sahu and Lambris, 2001) . Indeed, C3 is an acute-phase reactant produced in the liver and it is also a cytokine secreted by adipocytes and inflammation-activated macrophages (Choy et al., 1992) . Thus, an increase in C3 concentrations is associated, among other mediators, with cardiovascular disease features (Muscari et al., 2005) , insulin resistance, body weight gain (Engstrom et al., 2005a) , waist circumference and both high fasting and postpandrial triacylglycerol concentrations (Halkes et al., 2001) . These findings suggest that circulating C3 could be a risk factor on the development of obesity (Engstrom et al., 2005a) and type 2 diabetes (Engstrom et al., 2005b) , and a coronary disease risk indicator (Onat et al., 2005) . Moreover, C3 concentrations have been shown to be a useful biomarker to identify subjects with metabolic syndrome features (van Oostrom et al., 2007) .
In this context, the intake of selenium and other antioxidants has been associated with lower C-reactive protein (CRP) in women, suggesting a possible anti-inflammatory role for antioxidant nutrients (Scheurig et al., 2007) . Furthermore, a high selenium intake has been proposed to reduce the risk of diseases induced by oxidative stress and inflammation (Ferencik and Ebringer, 2003) and has been related to changes in lipid metabolism (Bleys et al., 2008) .
Smoking status, physical activity and alcohol intake as well as pharmacological treatments have been reported as possible factors related to inflammation and blood pressure levels in subjects with hypertension and metabolic disorders (Savoia and Schiffrin, 2007) .
The aim of this study was to evaluate the associations between serum C3 and several anthropometrical, biochemical and lifestyle features in healthy adults in order to identify this complement protein as an early predictor of metabolic syndrome manifestations emphasizing on the putative role of selenium intake on C3 concentrations.
Subjects and methods

Subjects
One hundred Caucasian healthy individuals were recruited to participate in the study (79 women and 21 men; age 20.7 ± 2.7 years). Initial enrolment screening evaluations included a medical history and a physical examination to exclude subjects with evidence of any disease related to chronic inflammation, oxidative stress, hydric imbalance, nutrient absorption and a fasting blood profile to exclude subjects with disorders linked to nutrient metabolism such as diabetes or dyslipidemia. Other exclusion criteria were drug or dietetic treatment up to 6 months before the participation in this study. In accordance with the Declaration of Helsinki (Benatar, 2004) , after a clear explanation of the study protocol, all subjects gave written informed consent to participate, which was previously approved by the Ethics Committee of the University of Navarra (ref:79/2005) . At the time of the initial interview, lifestyle issues were assessed.
Anthropometry and body composition measurements
All anthropometrical measurements were carried out with the participants barefoot, wearing only their underwear and after an overnight fast following standardized protocols (Gibson, 2005) . All these measurements were done three times, but not consecutively. Body weight was measured to the nearest 0.1 kg and body fat mass to the nearest 0.1% by using a Tanita TBF 300 (New York, USA). Body mass index (BMI) was calculated according to body weight divided by squared height (kg/m 2 ). Skinfold thicknesses (STs) were measured at the right side to the nearest 0.2 mm by means of a Holtain skinfold caliper (Holtain, Crymych, UK) at the triceps, the biceps, subscapular and suprailiac (Warnberg et al., 2006) . Waist and hip circumferences were measured with an inelastic tape to the nearest 1 mm. Blood pressure was measured by a mercury sphingomanometer Minimus II (Riester, Germany) to the nearest 5 mm Hg.
Analysis of biological samples
All serum blood samples were drawn after an overnight (12-h) fast, centrifuged immediately for 15 min at 3500 r.p.m. and 4 1C and stored at À80 1C. Serum glucose, triacylglycerols, total cholesterol and high-density lipoprotein cholesterol (HDL-c), were assessed by an automatized colorimetric assay (COBAS MIRA, Roche, Switzerland) with available specific commercial kits (ABX Pentra, Roche, Switzerland). The reported plasma low-density lipoprotein cholesterol (LDL-c) data were calculated by the Friedewald equation as described elsewhere (Friedewald et al., 1972) . Total serum C3 concentrations were determined using an automatized turbidimetric assay (COBAS MIRA, Roche, Switzerland). Insulin concentrations were measured by using an enzyme-linked immunosorbent assay (Mercodia, Uppsala, Sweden). For estimating insulin sensitivity, the homeostasis model assessment of insulin resistance (HOMA-IR) (glucose concentration Â insulin concentration/22.5) was calculated (Matthews et al., 1985) . Nail samples from most of the participants (92%) were collected at the time of interview and stored at room temperature in clean polypropylene bags labelled with subject identification numbers. Fingernails and toenails samples were treated with subboiling nitric acid in a high-pressure Teflon digestion vessel using a microwave digestion system (Ethos Plus, Millestone, Sorisole, Italy). Selenium concentrations were determined in sample digestions by Zeeman background correction graphite furnace atomic absorption spectrometry (ZGF-AAS; Perkin-Elmer Analyst 800; Perkin-Elmer Norwalk, CT, USA), under optimized operating conditions. Transversely heated graphite tubes with end caps supplied by Perkin-Elmer were used. An electrodeless discharge lamp (Perkin-Elmer) was operated at 280 mA. Samples and standards were atomized and all data were recorded at 196.0 nm with a slit width of 2.0 nm. The concentrations were adjusted for the sample weight and expressed as microgram per gram of nail.
Statistical analysis
The Kolmogorov-Smirnov test was used to determine variable distribution. Accordingly, the parametric Student's t-test or nonparametric Mann-Whitney U-test were performed to detect significant differences between subjects with C3 concentrations higher and lower than 1.085 g/l (median). Spearman's correlation coefficient was used to evaluate the association between variables. A multivariate linear regression model was fitted to further explain relations found between variables. Results are presented as mean ± s.d., confidence intervals (95% CI) are used to describe linear regression coefficient (B) values, and Po0.05 was considered statistically significant. Statistical analysis were performed by using SPSS version 13.0 (SPSS Inc., Chicago, IL, USA) for Windows XP (Microsoft, Redmond, WA, USA).
Results
Anthropometrical characteristics and biochemical determinations of subjects categorized according to serum C3 concentrations classification are described in Table 1 . Sex distribution had no differences between groups. However, statistically significant differences between subjects with higher and lower concentrations of circulating C3 were found for BMI and several adiposity measurements, serum triacylglycerols and nail selenium concentrations. In contrast, weight, waist circumference and waist-to-height ratio did not change significantly when split by C3 concentrations. No differences in concentrations of serum C3 were associated with systolic or diastolic blood pressures. No significant changes were found for circulating concentrations of glucose, insulin, HOMA-IR, total cholesterol, HDL-c and LDL-c (Table 1 ). The only statistically significant differences in biochemical parameters were found for serum triacylglycerols and nail selenium concentrations. Regarding the analyzed lifestyle features (Table 2) , no changes were detected for current multivitamin users, whereas subjects with higher serum C3 concentrations evidenced a higher percentage of smokers, and smoking more cigarettes per day. Moreover, participants with higher concentrations of C3 in serum appeared to do less physical activity, to have less percentage of subjects practising sport regularly and to feel being less active than subjects with lower circulating C3 concentrations. To further investigate the relationship between anthropometrical and biochemical characteristics with serum C3 concentrations as continuous variables, the following correlations were analyzed: tricipital ST (r ¼ 0.213, P ¼ 0.033), sum of four STs (r ¼ 0.249, P ¼ 0.012), BMI (r ¼ 0.265, P ¼ 0.008), body fat mass (r ¼ 0.236, P ¼ 0.018), waist-to-height ratio (r ¼ 0.241, P ¼ 0.016), serum glucose (r ¼ 0.201, P ¼ 0.045), serum triacylglycerols (r ¼ 0.331, P ¼ 0.001) and nail selenium (r ¼ À0.286, P ¼ 0.006). No correlations were found between C3 concentrations and smoking habits or physical activity. Linear regression analysis showed that C3 concentrations are positive predictors of BMI, waist circumference, waist-to-height ratio, body fat, serum glucose and triacylglycerols after adjusting for sex, multivitamin consumption, smoking status and selfperceived activity level (Table 3) . Finally, a multiple linear regression analysis showed nail selenium as a significant negative predictor of serum C3 concentrations after adjusting for sex and systolic blood pressure (Table 4) .
Discussion
The role of inflammation and oxidative stress on several chronic diseases is receiving increasing attention because of (Barnum and Volanakis, 1989 ) and C3, the only molecule able to activate by itself the three complement activation pathways (Choy et al., 1992) . Adipocytes, together with macrophages and hepatocytes, are an important source of C3 (Choy et al., 1992) , whose expression is higher in visceral than in subcutaneous adipose tissue (Gabrielsson et al., 2003) . Adipocytes are also responsible for factor B and adipsin secretion, which are involved in the alternative pathway of the complement system (Sniderman et al., 2000) . Furthermore, C3 together with factor B and adipsin activate the secretion of acylationstimulating protein (ASP) by adipocytes (Cianflone et al., 2003) . The correlations found between circulating concentrations of C3 and tricipital ST, sum of STs, BMI and body fat mass as well as the associations between serum C3 and BMI, waist circumference, waist-to-height ratio and body fat (Table 3) reveal that C3 is in some way related with several adiposity markers. These findings are in accordance with previous studies reporting the association between C3 and several adiposity measurements in healthy adolescents (Warnberg et al., 2006) , obese adults (Gabrielsson et al., 2003) and type 2 diabetic subjects (Kriketos et al., 2004) . Anthropometrical measurements, such as BMI (Halkes et al., 2001; Ylitalo et al., 2001; Onat et al., 2005) , waist circumference (Halkes et al., 2001; Onat et al., 2005) and waist-to-hip ratio (Ylitalo et al., 2001) , have been considered predictors of high C3 concentrations and have been related with higher expression in visceral than in subcutaneous white adipose tissue (Gabrielsson et al., 2003) . Thus, obese subjects have a higher C3 expression than lean men (Koistinen et al., 2001) .
The positive correlation between C3 concentrations and triacylglycerols is consistent with other studies (Onat et al., 2005; van Oostrom et al., 2007) . As ASP, a product derived from C3, rises the efficiency of synthesis of triacylglycerols in adipocytes, stimulating glucose absorption, activating the diacylglycerol acyltransferase (DGAT) and inhibiting the hormone-sensitive lipase (Sniderman et al., 2000) and high concentrations of C3 are able to increase circulating triacylglycerols (Maslowska et al., 1999) , the C3/ASP system has been hypothesized as a modulator of the fatty acid metabolism in adipose tissue. On the other hand, C3 knockout mice do not respond to a high fat diet with ethanol, tending to reduce liver steatosis (Bykov et al., 2006) . In addition, C3 concentrations lead to higher concentrations of circulating total cholesterol (Halkes et al., 2001; Ylitalo et al., 2001; Onat et al., 2005) and LDL-c (Halkes et al., 2001) , and to decreased concentrations of HDL-c (Yudkin, 2000; Ylitalo et al., 2001) . Also, high concentrations of C3 have been linked with hypertension (Yudkin, 2000) , and with both systolic and diastolic blood pressures (Halkes et al., 2001) . Furthermore, C3 has been associated for the first time with the waist-to-height ratio (Table 3) , an anthropometric measurement that has been related with cardiovascular and metabolic risk (Hsieh et al., 2003; Hsieh and Muto, 2005) . These evidences support the notion that elevated C3 concentrations are a cardiovascular risk factor (Yudkin, 2000; Ylitalo et al., 2001; Onat et al., 2005) and could be an early marker of cardiovascular risk.
Several groups have described a positive correlation between circulating C3 and glucose (Halkes et al., 2001; Ylitalo et al., 2001; Engstrom et al., 2005b) . In this sense, a previous study (Maslowska et al., 1999) explains these results through the ASP activity rising the glucose transport additively and independently of insulin mechanisms, and stimulating the diacylglycerol acyltransferase enzyme, involved in triacylglycerol synthesis pathway. In agreement with insulin concentrations, and in contrast to our results, positive correlation with circulating C3 has been described (Yudkin, 2000; Halkes et al., 2001; Ylitalo et al., 2001) , highlighting its possible role as a predictor of risk to develop type 2 diabetes and related metabolic disorders (Engstrom et al., 2005b) . In another study (van Oostrom et al., 2007) , C3 concentrations were related to HOMA-IR in both healthy adults and subjects with metabolic syndrome. Our study did not find any other associations between C3 and serum determinations. These relationships, as well as those found with adiposity markers, suggest that C3 is a good biochemical marker to identify subjects in risk to develop metabolic syndrome (van Oostrom et al., 2007) , defined as a clinical feature represented by the co-occurrence of multiple metabolic and vascular disorders (Fulop et al., 2006) . In this sense, C3 concentrations may be an early marker of these metabolic syndrome manifestations.
As C3 is associated with smoking status (Engstrom et al., 2005a) , risk factors of obesity (Engstrom et al., 2005a) , type 2 diabetes (Engstrom et al., 2005b) , cardiovascular diseases (Onat et al., 2005) and several complications associated with inflammation (Kriketos et al., 2004) and inflammatory biomarkers (Halkes et al., 2001; Sampietro et al., 2004) , C3 should be a good candidate as a marker of inflammation. However, we could not directly correlate smoking status neither physical activity with C3 concentrations although an effect of those variables was evident in our trial.
We report here for the first time an association between circulating C3 and nail selenium concentrations. Previously, some investigations have linked serum selenium concentrations with inflammatory biomarkers such as CRP, suggesting circulating CRP as a negative predictor of serum selenium (Ghayour-Mobarhan et al., 2005) . On the other hand, vitamin and mineral supplementation is associated with lower concentrations of CRP in women, specially with selenium and vitamin E supplementation (Scheurig et al., 2007) .
Several diseases related with inflammatory or oxidative processes might change the relations between inflammatory markers and antioxidant status. According to findings described for other diseases, the selenium decrease in liver and plasma during an acute-phase response is associated with an increase of CRP synthesis in liver (Maehira et al., 2002) . A decrease in nail selenium concentrations in subjects with inflammatory diseases compared with healthy subjects has been reported earlier (Musil et al., 2005) , highlighting the relation between inflammation and concentrations of antioxidants.
These results should be examined with care because of the lack of suitable selenium food content tables, which are important to confirm that nail selenium in this sample is also a reliable marker of selenium intake as has been suggested in previous studies (Hunter et al., 1990; Satia et al., 2006) . Moreover, further studies are needed with larger samples to confirm these translational data.
In conclusion, C3 seems to be related with selenium status and several anthropometrical and biochemical measurements linked to metabolic and cardiovascular disorders in apparently healthy young adults. These findings suggest a possible role for selenium intake in the decrease of C3, whose may be an early marker of metabolic syndrome manifestations and inflammatory-related features.
